Omicron Variant May Circumvent COVID-19 Antibody Cocktails

In COVID-19, Latest News by Precision Vaccinations

A leader in producing monoclonal antibody treatments confirmed today ‘there have been no direct in-clinic data testing against the SARS-CoV-2 virus variant known as Omicron.’
In today’s press release, New York-based Regeneron Inc. stated that the company is evaluating REGEN-COV® against the Omicron (B.1.1.529) variant.

Read More